ENOV vs WST · rev $1.17B vs P/E 35, rev $1.72B
Enovis Corp (ENOV) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Enovis Corp (ENOV) is a medical devices company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported ENOV revenue for 2026-07-03 was $1.17B. Net income was -$10.0M. Revenue was up 98.9% from 2026-04-03 to 2026-07-03. ENOV currently screens at market cap $1.37B.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
ENOV currently screens at market cap $1.37B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the ENOV and WST stock pages for the full models.
Not investment advice.